“Pharmacological Evaluation of New 4, 5-dihydro-1H- Pyrazole-1-yl acetate Derivatives as anti-cancer agents”, AJPS, vol. 22, no. 4, pp. 80–89, Jan. 2023, doi: 10.32947/ajps.v22i4.963.